Slide 1 - Oils Mentor

Download Report

Transcript Slide 1 - Oils Mentor

Medicinal and Therapeutic Usage

Commercial Production

What Makes an Oil Impure • • • • • • Enhancement of Compounds Removal of Compounds Addition of Compounds Synthetic Variants Impurities Blending With Inferior Grades Of Oil

Certified Pure Therapeutic Grade™

Sourcing • • • Habitat Cultivation Extraction Chemical Analysis • • • • • • Organoleptic MicroBiological Heavy Metal Gas Chromatography Mass Spectrometry FTIR

Indigenous Plants From Around the World

Organoleptic Evaluation Evaluation of the Essential Oils Physical and Aromatic Properties     Overall Appearance Color Flavor Odor

Microbiological Evaluation Evaluation of the Essential Oils Physical and Aromatic Properties  Total Plate Count  Total Coliforms  Bacteria  Salmonella  Yeast and Mold

Shelf Life Testing

Heavy Metal Testing Graphite Furnace Atomic Absorption Heavy Metals Inhibit Plants in the Following Ways • • • • Inhibits Growth Structure Damage Biological Activity Reduction Biochemical Alteration and Loss of Plant Function

FT-IR (Fourier Transform Infrared Spectrophotometer)

Gas Chromatograph / Mass Spectrometer

Gas Chromatography Separates the Sample Into Individual Components and Plots the Results on a Graph Shown as Peaks Mass Spectrometry Accurately Identifies the Components, Their Percent Value and Determines Origin

100% Pure NO Pesticides NO Fragrances NO Diluting Agents NO Solvents Nothing Artificial

d ō TERRA is Defining and Protecting the Quality of Essential Oils for the Benefit

Certified Pure Therapeutic Grade™

They Work!

Only from

We at dōTERRA are committed to sharing the life-enhancing benefits of therapeutic-grade essential oils and essential oil enhanced wellness products with the world.

Our mission as a company is to teach people to live more healthy, productive lives and to share with others the blessing of a lifetime of wellness.

Why

dōTERRA

?

dōTERRA Sales Growth since inception through Q1 2013 Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 Q9 Q10 Q11 Q12 Q13 Q14 Q15 Q16 Q17 Q18 Q19 Q20

U.S. Sales in April as a percent of total company Sales

2010: 84.2% 2011: 78.8% 2012: 72.4% 2013: 75.0%

Growth in mo. ordering IPCs in largest international markets

Taiwan Japan Australia

Growth in mo. ordering IPCs in the U.S

.

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57

Therapeutic-grade essential oils— a

natural

healthcare company.

Certified Pure Therapeutic Grade  © 2012 dōTERRA Holdings, LLC, Unauthorized duplication prohibited

Retention Facts

Fact #1: After 5 years of business, 80% of IPCs that have enrolled are still “active.” Fact #2: Of those that are “active,” 55% placed an order last month.

Fact #3: When considering IPCs who have placed orders within the last three months, more than 60% of all IPCs are “retained.” Fact #4: In the past year, retention is increasing !

What does this growth mean to the Company?

1. We are hiring new employees.

Headline:

2.

We are building new facilities.

Certified Pure Therapeutic Grade  © 2013 dōTERRA Holdings, LLC, Unauthorized duplication prohibited

3.

We are investing in inventory.

2012 Company Profits Income Taxes Inventory Balance 100% (40%) (52%) 8%

4.

We are increasing production capacity?

• • • • 2011: Outsourced to a third party 300,000 bottles/month 600 square meters Mostly a manual process Certified Pure Therapeutic Grade  © 2013 dōTERRA Holdings, LLC, Unauthorized duplication prohibited

4.

We are increasing our production capacity.

• • • • 2013: Owned by dōTERRA 3 million bottles per month Nearly 5,000 square meters Installation of 2 Rota Machines • Custom Designed • Made in Germany • Pharmaceutical Grade • Fills to within .001 ml.

Certified Pure Therapeutic Grade  © 2013 dōTERRA Holdings, LLC, Unauthorized duplication prohibited

5.

We are becoming more effective/efficient.

6. We are expanding internationally.

dōTERRA COMPENSATION PLAN PAYOUT September 2012 Rank Silver Gold Platinum Diamond Blue Diamond Presidential Diamond Lowest Highest Average $825 $1,186 $13,000 $16,470 $1,447 $3,628 $1,671 $6,266 $41,253 $7,935 $37,385 $13,975 $21,641 $99,990 $45,310 $48,318 $108,370 $65,459

dōTERRA COMPENSATION PLAN PAYOUT Rank in Months Silver Gold Platinum Diamond Blue Diamond Presidential Diamond Average 13 14.5 23 23 31 37 Most Common 3 5 20 23 33 n/a

Certified Pure Therapeutic Grade  © 2013 dōTERRA Holdings, LLC, Unauthorized duplication prohibited